I feel like me and the @microbesng.bsky.social marketing team would be great friends

A novel two-component system controls vancomycin resistance in epidemic Clostridioides difficile The glycopeptide antibiotic vancomycin is the frontline treatment for C. difficile infection in the UK. There have been only sporadic reports of resistance in the clinic but testing is rare so the tru...

New preprint from us! The latest part of our C. difficile vancomycin resistance story. We identified a new two-component system (VnrRS) that can control expression of the vanG pathway - just needs one amino acid change

@buddlejess.bsky.social @brockhurstlab.bsky.social @claireyt.bsky.social

Hard life being a pup in STEM

And the data was definitely worth waiting for! Once again evolution has come up with a solution that we would never have thought of and did not predict. Now to write the paper @buddlejess.bsky.social

New to Bluesky, but not to #microbio25 - great to be back at Micro soc and back in Liverpool 😁 Come say hi!